04.10.24
Kenvue plans to shutter its Los Angeles office. Neutrogena was created in Los Angeles in the the 1930s.
According to a California State Employment Development Department document, the permanent closure of that sapce will impact 84 employees.
Kenvue announced last year that it had signed a long-term lease for a newly renovated office and a newly constructed R&D building in Summit, NJ that, when opened, would serve as its new global headquarters.
In a statement provided to Happi, Kenvue said:
“We are evolving our operations to reach more consumers, optimize collaboration and broaden talent and career opportunities for all Kenvuers, and drive sustainable growth. As part of this, we will be consolidating operations from other sites to one location, our future world headquarters in Summit, NJ.
Decisions impacting our employees are never easy. We are fully committed to providing those affected by this change with the resources and support they may need.”
According to a 2023 SEC filing, Kenvue's move to the Summit, NJ campus is expected to commence in 2025 and continue through 2026 for the R&D space.
According to a California State Employment Development Department document, the permanent closure of that sapce will impact 84 employees.
Kenvue announced last year that it had signed a long-term lease for a newly renovated office and a newly constructed R&D building in Summit, NJ that, when opened, would serve as its new global headquarters.
In a statement provided to Happi, Kenvue said:
“We are evolving our operations to reach more consumers, optimize collaboration and broaden talent and career opportunities for all Kenvuers, and drive sustainable growth. As part of this, we will be consolidating operations from other sites to one location, our future world headquarters in Summit, NJ.
Decisions impacting our employees are never easy. We are fully committed to providing those affected by this change with the resources and support they may need.”
According to a 2023 SEC filing, Kenvue's move to the Summit, NJ campus is expected to commence in 2025 and continue through 2026 for the R&D space.